Pfizer Says COVID-19 Pill Cut Hospital, Death Risk By 90%


WASHINGTON (AP) — Pfizer says its experimental pill for COVID-19 cut rates of hospitalization and death by nearly 90% among patients with mild-to-moderate infections.

The company announced Friday it will soon ask the U.S. Food and Drug Administration and international regulators to authorize its pill, which is taken twice a day for five days.

A similar pill from competitor Merck is currently under FDA review and was cleared Thursday by U.K. regulators.

Drugmakers around the world have been racing to develop an easy-to-use pill to blunt the effects of COVID-19.

All therapies now authorized in the U.S. require an IV or injection.





Source link

About the Author

Leave a Reply

Your email address will not be published.

You may also like these